share_log

Relay Therapeutics Q4 2023 GAAP EPS $(0.67) Beats $(0.75) Estimate

Moomoo 24/7 ·  Feb 22 16:24

Relay Therapeutics (NASDAQ:RLAY) reported quarterly losses of $(0.67) per share which beat the analyst consensus estimate of $(0.75) by 10.67 percent.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment